Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-10-12

Clinical Trial Update: Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral nitazoxanide for bronchiolitis in infants presenting to emergency departments has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Telethon Kids Institute | Conditions: Bronchiolitis | Phase 2 | Status: WITHDRAWN